Celiac and the cranial mesenteric arteries supply gastrointestinal sites that regulate meal size and intermeal interval length via cholecystokinin-58 in male rats

Hormones and Behavior

Volumn 67, Issue , 2015, Pages 48-53

  Sayegh, Ayman I ^a   Washington, Martha C ^a   Johnson, Ruth E ^a   Johnson Rouse, Tanisha ^a   Freeman, Corren ^a   Harrison, Anna ^a   Lucas, Jennifer ^a   Shelby, Mandy ^a   Fisher, Brittley ^a   Willis, William ^a   Reeve, Joseph J ^a,b,c  

^a TUSKEGEE UNIVERSITY   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Celiac artery; Cholecystokinin 58; Cranial mesenteric artery; Intermeal interval; Meal size

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ 58; UNCLASSIFIED DRUG; CHOLAGOGUE;

ADULT; ANIMAL EXPERIMENT; APPETITE; ARTICLE; CELIAC ARTERY; CONTROLLED STUDY; CRANIAL MESENTERIC ARTERY; FEEDING BEHAVIOR; FEMORAL ARTERY; FOOD INTAKE; GASTROINTESTINAL TRACT; LIGHT DARK CYCLE; MALE; MEAL; MESENTERIC ARTERY; NONHUMAN; PORTAL VEIN; RAT; SATIETY; STOMACH BLOOD FLOW; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PSYCHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; SUPERIOR MESENTERIC ARTERY;

ANIMALS; CELIAC ARTERY; CHOLAGOGUES AND CHOLERETICS; CHOLECYSTOKININ; FEEDING BEHAVIOR; FEMORAL ARTERY; MALE; MESENTERIC ARTERY, SUPERIOR; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; SATIETY RESPONSE;

EID: 84916898821     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2014.11.011     Document Type: Article

References (43)

1. Berthoud H.R., Patterson L.M. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat. 1996, 156:123-131.
2. Buffa R., Solcia E., Go V.L. Immunohistochemical identification of the cholecystokinin cell in the intestinal mucosa. Gastroenterology 1976, 70:528-532.
3. Calingasan N., Ritter S., Ritter R., Brenner L. Low-dose near-celiac arterial cholecystokinin suppresses food intake in rats. Am. J. Physiol. 1992, 263:R572-R577.
4. Cooper M.S., Reeve J.R., Raboin S.J., Abdalla M.O., Green G.M., Sayegh A.I. Cholecystokinin-58 and cholecystokinin-8 produce similar but not identical activations of myenteric plexus and dorsal vagal complex. Regul. Pept. 2008, 148:88-94.
5. Corp E.S., McQuade J., Moran T.H., Smith G.P. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res. 1993, 623:161-166.
6. Corwin R.L., Gibbs J., Smith G.P. Increased food intake after type A but not type B cholecystokinin receptor blockade. Physiol. Behav. 1991, 50:255-258.
7. Cox J.E. Cholecystokinin satiety involves CCKA receptors perfused by the superior pancreaticoduodenal artery. Am. J. Physiol. 1998, 274:R1390-R1396.
8. Cox J.E., McCown S.M., Bridges J.M., Tyler W.J. Inhibition of sucrose intake by continuous celiac, superior mesenteric, and intravenous CCK-8 infusions. Am. J. Physiol. 1996, 270:R319-R325.
9. Cox J.E., Perdue G.S., Tyler W.J. Suppression of sucrose intake by continuous near-celiac and intravenous cholecystokinin infusions in rats. Am. J. Physiol. 1995, 268:R150-R155.
10. Eisen S., Phillips R.J., Geary N., Baronowsky E.A., Powley T.L., Smith G.P. Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R456-R462.
11. Gibbs J., Young R.C., Smith G.P. Cholecystokinin decreases food intake in rats. J. Comp. Physiol. Psychol. 1973, 84:488-495.
12. Glatzle J., Raybould H.E., Kueper M.A., Reeve J.R., Zittel T.T. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats. Nutr. Neurosci. 2008, 11:69-74.
13. Goebel-Stengel M., Stengel A., Wang L., Ohning G., Tache Y., Reeve J.R. CCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 303:R850-R860.
14. Greenberg D., Smith G.P. Hepatic-portal infusion reduces the satiating potency of CCK-8. Physiol. Behav. 1988, 44:535-538.
15. Greenberg D., Smith G.P., Gibbs J. Infusion of CCK-8 into hepatic-portal vein fails to reduce food intake in rats. Am. J. Physiol. 1987, 252:R1015-R1018.
16. Gulley S., Sharma S.K., Mansour M., Sullivan C.N., Moran T.H., Sayegh A.I. Strain differences in myenteric neuron number and CCK1 receptor mRNA expression may account for differences in CCK induced c-Fos activation. Brain Res. 2005, 1058:109-119.
17. Harper A.A., Raper H.S. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J. Physiol. 1943, 102:115-125.
18. Ivy A.C., Oldberg E.A. A hormone mechanism for gallbladder contraction and evacuation. Am. J. Physiol. 1928, 86:599-613.
19. Kreis M.E., Zittel T.T., Raybould H.E., Reeve J.R., Grundy D. Prolonged intestinal afferent nerve discharge in response to cholecystokinin-58 compared to cholecystokinin-8 in rats. Neurosci. Lett. 1997, 230:89-92.
20. Lateef D.M., Washington M.C., Raboin S.J., Roberson A.E., Mansour M.M., Williams C.S., Sayegh A.I. Duodenal myotomy blocks reduction of meal size and prolongation of intermeal interval by cholecystokinin. Physiol. Behav. 2012, 105:829-834.
21. Lateef D.M., Washington M.C., Sayegh A.I. The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval. Peptides 2011, 32:1289-1295.
22. Moran T.H., Shnayder L., Hostetler A.M., McHugh P.R. Pylorectomy reduces the satiety action of cholecystokinin. Am. J. Physiol. 1988, 255:R1059-R1063.
23. Overduin J., Gibbs J., Cummings D.E., Reeve J.R. CCK-58 elicits both satiety and satiation in rats while CCK-8 elicits only satiation. Peptides 2014, 54:71-80.
24. Owyang C., Heldsinger A. Vagal control of satiety and hormonal regulation of appetite. J. Neurogastroenterol. Motil. 2011, 17:338-348.
25. Patterson L.M., Zheng H., Berthoud H.R. Vagal afferents innervating the gastrointestinal tract and CCKA-receptor immunoreactivity. Anat. Rec. 2002, 266:10-20.
26. Patterson L.M., Zheng H., Ward S.M., Berthoud H.R. Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res. 2003, 311:277-287.
27. Polak J.M., Bloom S.R., Rayford P.L., Pearse A.G., Buchan A.M., Thompson J.C. Identification of cholecystokinin-secreting cells. Lancet 1975, 2:1016-1018.
28. Qian M., Wu G.S., Adem A., Johnson A.E., Sodersten P. CCK-8 can inhibit ingestive behavior by acting on the liver. Neuroreport 1999, 10:359-362.
29. Raboin S.J., Reeve J.R., Cooper M.S., Green G.M., Sayegh A.I. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat. Regul. Pept. 2008, 150:73-80.
30. Raybould H.E., Tache Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am. J. Physiol. 1988, 255:G242-G246.
31. Reeve J.R., Green G.M., Chew P., Eysselein V.E., Keire D.A. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G255-G265.
32. Reeve J.R., Wu S.V., Keire D.A., Faull K., Chew P., Solomon T.E., Green G.M., Coskun T. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G395-G402.
33. Richter C.P. A behavioristic study of the activity of the rat. J. Comp. Psychol. 1922, 1:1-55.
34. Richter C.P. Animal behavior and internal drives. Q. Rev. Biol. 1927, 2:307-343.
35. Rom D.M. An improved Hochberg procedure for multiple tests of significance. Br. J. Math. Stat. Psychol. 2013, 66:189-196.
36. Sayegh A.I. The role of cholecystokinin receptors in the short-term control of food intake. Prog. Mol. Biol. Transl. Sci. 2013, 114:277-316.
37. Sayegh A.I., Washington M.C., Raboin S.J., Aglan A.H., Reeve J.R. CCK-58 prolongs the intermeal interval, whereas CCK-8 reduces this interval: not all forms of cholecystokinin have equal bioactivity. Peptides 2014, 55:120-125.
38. Sullivan C.N., Raboin S.J., Gulley S., Sinzobahamvya N.T., Green G.M., Reeve J.R., Sayegh A.I. Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R1071-R1080.
39. Voigt J.P., Wenz D., Voits M., Fink H. Does increased endogenous CCK interact with serotonin to reduce food intake in rats?. Peptides 2000, 21:1895-1901.
40. Washington M.C., Aglan A.H., Sayegh A.I. The stomach and/or upper duodenum contain sites of action that control meal size and intermeal interval length by exogenous rat gastrin releasing peptide. Peptides 2014, 55C:41-46.
41. Washington M.C., Aglan A.H., Sayegh A.I. The stomach and/or upper duodenum contain sites of action that control meal size and intermeal interval length by exogenous rat gastrin releasing peptide. Peptides 2014, 55:41-46.
42. Yamamoto M., Reeve J.R., Green G.M. Supramaximal CCK-58 does not induce pancreatitis in the rat: role of pancreatic water secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G964-G974.
43. Yamamoto M., Reeve J.R., Keire D.A., Green G.M. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G866-G879.